PHARMACOLOGICAL EFFECT OF EZH2 INHIBITOR IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA

被引：0
|
作者：
Iannotta, A. [1 ]
Ramaglia, M. [1 ]
Lombardi, A. [1 ]
D'Angelo, V. [1 ]
Caraglia, M. [1 ]
Affinita, M. C. [1 ]
Fusco, C. [1 ]
Di Martino, M. [1 ]
Di Pinto, D. [1 ]
Oreste, M. [1 ]
Indolfi, C. [1 ]
Indolfi, P. [1 ]
Casale, F. [1 ]
机构：
[1] Univ Naples 2, Naples, Italy
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-022
引用
收藏
页码：S258 / S259
页数：2
相关论文
共 50 条
  • [21] Update on biology and treatment of T-cell acute lymphoblastic leukaemia
    Patrick, Katharine
    Vora, Ajay
    CURRENT OPINION IN PEDIATRICS, 2015, 27 (01) : 44 - 49
  • [22] The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy
    Ying Wang
    Tien Bui
    Yi Zhang
    International Journal of Hematology, 2022, 116 : 837 - 845
  • [23] Distinctive genotypes in infants with T-cell acute lymphoblastic leukaemia
    Mansur, Marcela B.
    van Delft, Frederik W.
    Colman, Susan M.
    Furness, Caroline L.
    Gibson, Jane
    Emerenciano, Mariana
    Kempski, Helena
    Clappier, Emmanuelle
    Cave, Helene
    Soulier, Jean
    Pombo-de-Oliveira, Maria S.
    Greaves, Mel
    Ford, Anthony M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (04) : 574 - 584
  • [24] EZH2: a potential new target in T-cell lymphoma?
    Giulino-Roth, Lisa
    LEUKEMIA & LYMPHOMA, 2015, 56 (07) : 1924 - 1925
  • [25] Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma
    Pikman, Yana
    Conway, Amy Saur
    Robichaud, Amanda L.
    Kitara, Samuel
    Church, Alanna J.
    Kennedy, Alyssa L.
    Silverman, Lewis B.
    Billett, Amy L.
    Weinstock, David M.
    Harris, Marian H.
    Stegmaier, Kimberly
    BLOOD ADVANCES, 2020, 4 (07) : 1265 - 1269
  • [26] Recurrent histone mutations in T-cell acute lymphoblastic leukaemia
    Collord, Grace
    Martincorena, Inigo
    Young, Matthew D.
    Foroni, Letizia
    Bolli, Niccolo
    Stratton, Michael R.
    Vassiliou, George S.
    Campbell, Peter J.
    Behjati, Sam
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) : 676 - 679
  • [27] The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy
    Wang, Ying
    Bui, Tien
    Zhang, Yi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (06) : 837 - 845
  • [28] T-cell acute lymphoblastic leukaemia: recent molecular biology findings
    Kraszewska, Monika D.
    Dawidowska, Malgorzata
    Szczepanski, Tomasz
    Witt, Michal
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (03) : 303 - 315
  • [29] The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
    Jinghui Zhang
    Li Ding
    Linda Holmfeldt
    Gang Wu
    Sue L. Heatley
    Debbie Payne-Turner
    John Easton
    Xiang Chen
    Jianmin Wang
    Michael Rusch
    Charles Lu
    Shann-Ching Chen
    Lei Wei
    J. Racquel Collins-Underwood
    Jing Ma
    Kathryn G. Roberts
    Stanley B. Pounds
    Anatoly Ulyanov
    Jared Becksfort
    Pankaj Gupta
    Robert Huether
    Richard W. Kriwacki
    Matthew Parker
    Daniel J. McGoldrick
    David Zhao
    Daniel Alford
    Stephen Espy
    Kiran Chand Bobba
    Guangchun Song
    Deqing Pei
    Cheng Cheng
    Stefan Roberts
    Michael I. Barbato
    Dario Campana
    Elaine Coustan-Smith
    Sheila A. Shurtleff
    Susana C. Raimondi
    Maria Kleppe
    Jan Cools
    Kristin A. Shimano
    Michelle L. Hermiston
    Sergei Doulatov
    Kolja Eppert
    Elisa Laurenti
    Faiyaz Notta
    John E. Dick
    Giuseppe Basso
    Stephen P. Hunger
    Mignon L. Loh
    Meenakshi Devidas
    Nature, 2012, 481 : 157 - 163
  • [30] Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia
    Cerrano, Marco
    Castella, Barbara
    Lia, Giuseppe
    Olivi, Matteo
    Faraci, Danilo G.
    Butera, Sara
    Martella, Federica
    Scaldaferri, Matilde
    Cattel, Francesco
    Boccadoro, Mario
    Massaia, Massimo
    Ferrero, Dario
    Bruno, Benedetto
    Giaccone, Luisa
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (01) : E28 - E32
12345